Hypericum Neem Oil Topical Composition for Epidermolysis Bullosa

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for epidermolysis bullosa lack definitive effectiveness, primarily focusing on preventing complications and relieving pain, with no established method to prevent tissue destruction or ensure optimal wound healing and quality of scars.

Innovation Solution

A composition comprising an extract of Hypericum in Neem oil, prepared by combining Hypericum flowers or capsules with Neem oil in a specific weight ratio, is administered topically, utilizing a method described in European patent EP 2 185 168, and demonstrated to be effective in reducing lesion size and preventing further tissue damage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional wound treatments are used for epidermolysis bullosa, then basic wound care is provided, but tissue destruction cannot be prevented and scar quality is not optimized

Engineering Contradiction:
Improveeffectiveness of treatmentVSAvoidavailability of definitive treatment
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The invention combines Hypericum extract and Neem oil into a composite topical composition that synergistically provides anti-inflammatory, antiseptic, and cicatrizing properties. This composite material addresses the inadequacy of single-agent treatments by integrating multiple bioactive components that work together to prevent tissue destruction and optimize wound healing in epidermolysis bullosa patients.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The topical composition acts as an intermediary substance applied between the traumatic environment and the vulnerable skin of epidermolysis bullosa patients. It mediates the interaction by providing a protective barrier and delivering therapeutic agents directly to the wound site, thereby preventing tissue destruction and promoting optimal healing without requiring systemic intervention.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If multiple systemic medications are administered, then disease symptoms are managed, but definitive treatment and prevention of tissue destruction remain unavailable

Engineering Contradiction:
Improverange of treatment optionsVSAvoiddefinitive effectiveness
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The invention segments the treatment approach by moving from systemic medication to localized topical application. This segmentation allows the therapeutic action to be concentrated precisely where needed - at the wound site - rather than distributing medication throughout the body. The topical composition delivers high concentrations of active ingredients directly to affected areas, providing definitive treatment for local tissue damage.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention extracts the essential therapeutic functions from complex systemic regimens and concentrates them into a single topical formulation. By taking out the key cicatrizing, anti-inflammatory, and antiseptic properties and encapsulating them in the Hypericum-Neem composition, the invention provides a simplified yet definitive treatment that directly addresses tissue destruction without requiring multiple systemic medications.

Inventive Principle:
Principle #2Taking out (Extraction)

3Object-affected harmful factors

If supportive care measures are implemented, then complications are prevented, but wound healing optimization and scar minimization are not achieved

Engineering Contradiction:
Improvecomplication preventionVSAvoidwound healing effectiveness
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The topical composition performs preliminary protective action by being applied preventively to vulnerable skin areas before trauma occurs. It proactively creates a protective environment that prevents tissue destruction and prepares the skin for optimal healing. This preliminary intervention goes beyond reactive complication management by establishing therapeutic conditions in advance.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention converts the inherently vulnerable state of epidermolysis bullosa skin into an opportunity for optimized healing. By applying the cicatrizing composition to wounded areas, it transforms what would be destructive trauma into a controlled healing process that minimizes scarring and maximizes tissue regeneration. The harmful trauma is converted into a beneficial therapeutic opportunity through the active ingredients.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition significantly reduces lesion size, prevents tissue destruction, maintains skin elasticity, minimizes scarring, and reduces pain, demonstrating advanced preventive medication properties with no adverse effects on perilesional skin, as shown in a clinical study.

Implementation Method 1

the oily solution or the hypericum extract has anti-inflammatory effect, antiseptic and cicatrizing in the external wounds, ulcers and bums

Methodology Applied
Scientific EffectAnti-inflammatory effect:

Implementation Method 2

the oily solution or the hypericum extract has anti-inflammatory effect, antiseptic and cicatrizing in the external wounds, ulcers and bums

Methodology Applied
Scientific EffectCicatrizing effect:

Implementation Method 3

the oily solution or the hypericum extract has anti-inflammatory effect, antiseptic and cicatrizing in the external wounds, ulcers and bums

Methodology Applied
Scientific EffectAntiseptic effect:

Implementation Method 4

the Neem oil has cicatrizing, biocide, anti-inflammatory, myasis insect repellent and not proprieties

Methodology Applied
Scientific EffectBiocide effect:

Implementation Method 5

demonstrating advanced preventive medication properties with no adverse effects on perilesional skin, as shown in a clinical study

Methodology Applied
Scientific EffectPain reduction:

Data Source

PatentEP4217061B1Hypericum extract in neem oil for the treatment of epidermolysis bullosa
Publication Date: 2024.09.11 RI MOS
  • EP4217061B1 patent drawingFigure 1~2
  • EP4217061B1 patent drawingFigure 3~4

AI summary

It is described a composition comprising a Hypericum extract in Neem oil for use in the treatment of epidermolysis bullosa, a genetic skin disease.